We currently do not have sufficient information about the CEO.
Key information
Telemaque Lavidas
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
2.6yrs
CEO ownership
n/a
Management average tenure
2.6yrs
Board average tenure
5.2yrs
Recent management updates
Recent updates
CEO
Telemaque Lavidas
2.6yrs
Tenure
Mr. Telemaque Jean Lavidas is Director of Center For Community Alternatives, Inc. Telemaque Lavidas serves as the President of Lavipharm Group International, a diversified healthcare group of companies act...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Telemaque Lavidas
CEO & Executive Board Member
2.6yrs
no data
no data
Vassilis Baloumis
Group CFO & Investor Relations Officer
4.7yrs
no data
no data
Panagiotis Kousoulis
Chief Manufacturing & Operations Officer
no data
no data
no data
Evangelos Paterakis
Chief Accountant
no data
no data
no data
Mariza Antonaki
Chief People & Technology Officer
2.6yrs
no data
no data
Nikos Ladas
Chief Scientific Officer
2.6yrs
no data
no data
Eleana Nikolopoulou
Director of Legal & Compliance and Corporate Secretary
4.4yrs
no data
no data
Ilias Konstantopoulos
Director of Marketing & Sales CHC
no data
no data
no data
Katerina Tsardaka
Director of Business Development & Acquisitions
2.6yrs
no data
no data
Panagiotis Giannouleas
Deputy CEO & Director
2.6yrs
no data
no data
Emmanouil Petrou
Head of Medical Affairs of Lavipharm Hellas
no data
no data
no data
Ioannis Sarigiannidis
Chief Commercial Officer International
2.6yrs
no data
no data
2.6yrs
Average Tenure
Experienced Management: BXA0's management team is considered experienced (2.6 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Telemaque Lavidas
CEO & Executive Board Member
7.2yrs
no data
no data
Panagiotis Giannouleas
Deputy CEO & Director
2.6yrs
no data
no data
Venetsiana-Loukia Lavida
Vice Chairman of the Board
no data
no data
no data
Christos Diamandopoulos
Non Executive Director
no data
no data
no data
James Christopoulos
Independent Non Executive Director
no data
no data
no data
Vicky Kefalas
Independent Non-Executive Board Member
3.6yrs
no data
no data
Sophia Kounenaki-Efraimoglou
Independent Chairperson of the Board
6.8yrs
no data
no data
5.2yrs
Average Tenure
Experienced Board: BXA0's board of directors are considered experienced (5.2 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/08/10 20:43
End of Day Share Price
2026/08/10 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lavipharm S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.